Skip to main content

Table 4 Cardiovascular risk assessments of smokers, CV ASPIRE study, Europe, 2011

From: Smoking cessation and the risk of cardiovascular disease outcomes predicted from established risk scores: Results of the Cardiovascular Risk Assessment among Smokers in Primary Care in Europe (CV-ASPIRE) Study

Cardiovascular risk Risk score n Smokers (a) (N=1439) Hypothetical non-smokers (b) (N=1439) Risk difference (a-b) Risk ratio (a-b/b)
10-year Cardiovascular Mortality Risk, mean % (range) SCORE 1419 4.0% (0%-26%) 2.0% (0%-14%) 2.0% 100%
10-year Coronary Heart Disease Risk, mean % (range) Framingham 1275 17.9% (1%-84%) 11.9% (1%-66%) 6.0% 50%
10-Year Cardiovascular Disease Risk, mean % (range) Framingham 1368 21.2% (2%-30%) 16.0% (1%-30%) 5.1% 32%
10-Year Hard Coronary Heart Disease Risk, mean % (range) Framingham 1372 13.2% (0%-49%) 8.0% (0%-48%) 5.2% 65%
4-Year Intermittent Claudication Risk, mean % (range) Framingham 1161 2.8% (0%-36%) 1.5% (0%-20%) 1.3% 87%
2-Year Recurring Coronary Heart Disease Risk (amongst females with history of CHD), mean % (range) Framingham 68 6.4% (2%-21%) 4.5% (1%-15%) 1.8% 40%
10-Year Risk (%) of Coronary or Cardiovascular Event, mean % (range) Progetto CUORE 1117 10.3% (0%-77%) 6.2% (0%-58%) 4.2% 68%